No trials match your search ""

• Molecular and Cellular Analysis of Breast Cancer

  Stanford is currently accepting patients for this trial.

• Intraoperative Detection of Residual Cancer in Breast Cancer

  Stanford is currently accepting patients for this trial.

• Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer

  Stanford is currently accepting patients for this trial.

• Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC

  Stanford is currently accepting patients for this trial.

• Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• G1T48, an Oral SERD, in ER-Positive, HER2-Negative Advanced Breast Cancer

  Stanford is currently accepting patients for this trial.

• Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma

  Stanford is currently accepting patients for this trial.

• Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

  Stanford is currently accepting patients for this trial.

• Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Phase II Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

  Stanford is currently accepting patients for this trial.

• Magnetic Resonance Imaging of Breast Cancer

  Stanford is currently accepting patients for this trial.

• Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema

  Stanford is currently accepting patients for this trial.

• Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

  Stanford is currently accepting patients for this trial.

• Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

  Stanford is currently accepting patients for this trial.

• Phase II Talazoparib in BRCA1 +BRCA2 Wild-Type &Triple-Neg /HER2-Negative Breast Cancer /SolidTumors

  Stanford is currently accepting patients for this trial.

• Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• 4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer

  Stanford is currently accepting patients for this trial.

• A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

  Stanford is currently accepting patients for this trial.

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

• International Lymphatic Disease and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

• Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

  Stanford is currently accepting patients for this trial.

• A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

  Stanford is currently accepting patients for this trial.

• Assessment of Patient Experience During Treatment for Cancer

  Stanford is currently accepting patients for this trial.

• Pembrolizumab and Interferon Gamma-1b in Treating Patients With Stage IB-IVB Relapsed or Refractory Mycosis Fungoides and Sezary Syndrome

  Stanford is currently accepting patients for this trial.

• PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy

  Stanford is currently accepting patients for this trial.

• Pembrolizumab Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

  Stanford is currently accepting patients for this trial.

• Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

  Stanford is currently accepting patients for this trial.

• Pre-Operative Cemiplimab Administered Intralesionally for Patients With Recurrent Cutaneous Squamous Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)

  Stanford is currently accepting patients for this trial.

• Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma

  Stanford is currently accepting patients for this trial.

• A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)

  Stanford is currently accepting patients for this trial.

• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

  Stanford is currently accepting patients for this trial.

• A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma

  Stanford is currently accepting patients for this trial.

• ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma

  Stanford is currently accepting patients for this trial.

• Selinexor in Advanced Liposarcoma

  Stanford is currently accepting patients for this trial.

• Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

  Stanford is currently accepting patients for this trial.

• Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds

  Stanford is currently accepting patients for this trial.

No trials match your search ""